跳至主要内容
临床试验/ACTRN12613000707763
ACTRN12613000707763撤回未知

A Study to Evaluate the short term clinical outcomes of GALA (Trademark) Vascular Conduit Preservation Solution in Patients Undergoing Coronary Artery Bypass Graft Surgery.

Mobius Medical Pty Ltd0 个研究点目标入组 25 人开始时间: 2013年6月28日最近更新:

试验速览

阶段
未知
状态
撤回
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • *Adults age >18 to <75 years
  • *Patients undergoing first time elective or urgent CABG-only procedure
  • *Patients with at least 1 planned SVG
  • *Left ventricular ejection fraction (LVEF) >50%
  • *Female patients must be surgically sterile or postmenopausal
  • *Willingness, ability, and commitment to participate in a follow-up evaluation including a clinic visit at 30 days after the study procedure

排除标准

  • * In-situ IMA graft(s) only (no SVG)
  • * Prior CABG or planned concomitant valve surgery or aortic aneurysm repair
  • * Any clinically significant valve disease
  • * Left ventricular ejection fraction (LVEF) <50%
  • * Myocardial Infarction within 2 weeks of screening
  • * Creatinine >177 micro mol/l
  • * Vasculitis or another nonatherosclerotic cause of CAD
  • * Hypercoagulable state
  • * Any condition or disease detected that would render the patient unsuitable for the study
  • * Involvement in another drug or device study within 30 days
  • * Inability of the patient to provide informed consent

研究者

相似试验